Maternal polycystic ovary syndrome and the risk of neurodevelopmental disorders in preterm neonates
Pediatric Endocrinology Diabetes and Metabolism · 2026 · 32 (2) · 115-120
DOI: 10.5114/pedm.2026.161348 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Endocrinology Diabetes and Metabolism, 2026. Verfasst von Noorjan Muhammed und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics, College of Medicine, University of Kirkuk, Iraq. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Neurodevelopmental Disorders, Infant, Premature, Pregnancy Complications. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Paediatrics, College of Medicine, University of Kirkuk, Iraq.
- Department of Medicine, College of Medicine, University of Kirkuk, Iraq.
- Department of Obstetrics and Gynecology, College of Medicine, University of Kirkuk, Iraq.
- Department of Obstetrics and Gynaecology, Mustansiriyah University, Baghdad, Iraq. dr.wassan76@uomustansiriyah.edu.iq.
Zitieren
APA
Muhammed, N., Taha, M., Mohammed, E., & Nori, W. (2026). Maternal polycystic ovary syndrome and the risk of neurodevelopmental disorders in preterm neonates. Pediatric Endocrinology Diabetes and Metabolism, 32(2), 115-120. https://doi.org/10.5114/pedm.2026.161348
Vancouver
Muhammed N, Taha M, Mohammed E, Nori W. Maternal polycystic ovary syndrome and the risk of neurodevelopmental disorders in preterm neonates. Pediatric Endocrinology Diabetes and Metabolism. 2026;32(2):115-120. doi:10.5114/pedm.2026.161348
BibTeX
@article{Muhammed2026,
author = {Muhammed, Noorjan and Taha, Mufeed and Mohammed, Esraa and Nori, Wassan},
title = {Maternal polycystic ovary syndrome and the risk of neurodevelopmental disorders in preterm neonates},
journal = {Pediatric Endocrinology Diabetes and Metabolism},
year = {2026},
volume = {32},
number = {2},
pages = {115--120},
doi = {10.5114/pedm.2026.161348}
}
EUVIMED